Of note, in our previous studies we observed that the overexpression of FGFR1 in pancreatic cancer was linked to a low-grade tumor and the better survival of patients, suggesting that it may serve as a good prognostic marker [23]. This evidence concerns the gene FGFR1 and familial pancreatic carcinoma.